z-logo
Premium
Hyperaminoacidemia eliminates the influence of body fat and insulin sensitivity on fractional synthesis rate and myostatin regulation in humans (1168.3)
Author(s) -
Tran Lee,
Masters Haley,
Katsanos Christos
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.1168.3
Subject(s) - medicine , endocrinology , myostatin , insulin resistance , skeletal muscle , insulin , carbohydrate metabolism , metabolism , chemistry
Multiple conditions are linked to perturbed skeletal muscle protein (SMP) metabolism, including excess adiposity and insulin resistance. Here we delineate the precise roles of body fat and insulin sensitivity on SMP metabolism, and test the hypothesis that hyperaminoacidemia can eliminate the influence of these factors. Six healthy individuals underwent a DEXA scan to determine percent body fat (%BF; 16.3‐29.4%) and an oral glucose tolerance test (OGTT) to evaluate insulin sensitivity via Matsuda index (MI; 1.21‐12.0). Subjects received a primed, continuous infusion of L‐[2,3,3,4,5,5,5,6,6,6‐ 2 H 10 ]leucine to determine SMP fractional synthesis rate (FSR) in biopsies from the vastus lateralis . Myostatin (MSTN) mRNA, a marker of muscle wasting, was quantified in similar biopsies, and MSTN activation was assessed in plasma as the percent of active over latent protein. To evaluate the effect of hyperaminoacidemia, samples were collected before and during infusions of high amino acids (AA). In our subjects, %BF was not correlated with MI ( P =0.11). The %BF was only associated with MSTN mRNA ( P =0.02; r=0.81). However, MI was a key determinant in FSR ( P =0.02; r=0.83) and MSTN activation ( P <0.01; r=‐0.94). AA infusion eliminated all discrepancies in FSR and MSTN quantitations. Thus, SMP metabolism is more strongly linked to insulin sensitivity than body fat, but the influence is attenuated with hyperaminoacidemia. Grant Funding Source : Supported by NIH/NIDDK Grant# R01 DK094062; NCATS Grant# UL1 TR000135

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here